Zevra Therapeutics Quote - ZVRA

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

6.559

Bid

6.52

Offer

6.56

Volume

12,817

0.00 Day's Range 0.00

3.89 52 Week Range 7.28

Market Cap

260.747M

Previous Close

6.23

Open

Last Trade

6.55

Last Trade Time

22:36:57

Financial Volume

VWAP

Average Volume (3m)

263,426

Shares Outstanding

41,853,494

Dividend Yield

PE Ratio

-5.66

Earnings Per Share (EPS)

-1.1

Revenue

27.46M

Net Profit

-46.05M

Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and ... Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kempharm.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Zevra Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZVRA. The last closing price for Zevra Therapeutics was US$6.23. Over the last year, Zevra Therapeutics shares have traded in a share price range of US$ 3.89 to US$ 7.28.

Zevra Therapeutics currently has 41,853,494 shares in issue. The market capitalisation of Zevra Therapeutics is US$260.75 million. Zevra Therapeutics has a price to earnings ratio (PE ratio) of -5.66.

Overall Flow

Bullish

Net Premium

508k

Calls / Puts

100.00%

Buys / Sells

200.00%

OTM / ITM

200.00%

Sweeps Ratio

Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders

CELEBRATION, Fla. and ELK GROVE VILLAGE, Ill., June 18, 2024 (GLOBE NEWSWIRE) -- Orsini Specialty Pharmacy (Orsini), and Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra) today announced that...

Form EFFECT - Notice of Effectiveness

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.999	43.8377192982	4.56	6.25	4.475	769239	5.78109666	CS
4	1.989	43.52297593	4.57	6.25	4.2	448685	5.17419942	CS
12	1.969	42.8976034858	4.59	6.25	4.2	263426	4.988748	CS
26	0.709	12.1196581197	5.85	7.28	4.2	253519	5.43037073	CS
52	1.799	37.7941176471	4.76	7.28	3.89	220599	5.29293665	CS
156	0.909	16.0884955752	5.65	7.28	3.89	241135	5.27522115	CS
260	0.909	16.0884955752	5.65	7.28	3.89	241135	5.27522115	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
1MCMorella Corporation Ltd	AUD 0.049 (1,533.33%)	158.83k
MSGMCS Services Limited	AUD 0.005 (400.00%)	26.31M
OSXOOsteopore Limited	AUD 0.007 (250.00%)	257.33k
DGRDGR Global Limited	AUD 0.03 (233.33%)	46.76M
LBTOALBT Innovations	AUD 0.009 (125.00%)	300k
VPRVolt Group Ltd	AUD 0.001 (-50.00%)	1.01M
1TTThrive Tribe Technologies Ltd	AUD 0.002 (-33.33%)	8.15M
ARVOCArtemis Resources Limited	AUD 0.002 (-33.33%)	4.92M
SIHSihayo Gold Limited	AUD 0.002 (-33.33%)	208k
SHOSportshero Limited	AUD 0.005 (-28.57%)	3.08M
DRODroneShield Limited	AUD 1.995 (-22.67%)	57.82M
NGSNutritional Growth Solutions Ltd	AUD 0.004 (33.33%)	54.75M
LSRLodestar Minerals Limited	AUD 0.001 (0.00%)	53.43M
DGRDGR Global Limited	AUD 0.03 (233.33%)	46.76M
OSXOsteopore Limited	AUD 0.065 (18.18%)	33.47M